TCL Archive Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says November 29, 1996
TCL Archive House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures May 21, 1993
TCL Archive In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB October 7, 1983
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories October 6, 1978
